+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Japan In-Vitro Diagnostics Market (by Segment and Company), Size, Share, Major Deals, Trends, Company Analysis and Recent Developments - Forecast to 2030

  • PDF Icon

    Report

  • 218 Pages
  • February 2024
  • Region: Japan
  • iGATE Research
  • ID: 5822861

Japan's in-vitro diagnostics market is predicted to reach US$ 6.62 Billion by 2030, from US$ 4.59 Billion in 2023. Japan is one of the leading in-vitro diagnostics markets in the Asia-Pacific region. In-vitro diagnostics refers to the diagnosis of disease or other conditions of the human body through the collection, preparation, and testing of human samples with reagents, instruments, and systems.

Japan is facing the challenges of fighting infectious diseases including HBV, TB, HCV, and HIV, as well as various chronic diseases and cancer. The population of Japan is aging rapidly. For instance, as of September 2023, close to 36.23 million people in Japan were estimated to be within the age group of 65 and over. Japan’s quickly aging population leads to an explosion of chronic conditions such as heart disease and cancer. All of these conditions can be diagnosed and monitored using IVD products. However, some of the factors limiting the growth of the market are a lack of proper reimbursement policies and a stringent regulatory framework.

Japan In-Vitro Diagnostics (IVD) Market - Recent Developments

  • In January 2024, bioMérieux announced the acquisition of LUMED, a software company that has developed a clinical decision support system to help hospitals optimize antimicrobial prescriptions and monitor healthcare-associated infections.
  • In August 2023, Sysmex Corporation announced an expansion of the Global Business Partnership Agreement (GBPA) with Roche Diagnostics International Ltd.
  • In April 2023, Oxford Nanopore Technologies plc, and bioMérieux SA teamed up to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics market.
  • In October 2023, Sysmex and Fujirebio entered into a business collaboration agreement in the field of immunoassay, in a bid to promote cooperation to accelerate their global expansion, and to contribute to the development and advancement of immunoassay.
  • In December 2022, bioMérieux announced the CE-marking of VIDAS KUBE, the next-generation automated immunoassay system for the VIDAS range.

By Segment: Japan IVD Market and Forecast - Key Takeaways

  • On a segment basis, immunology and genetic testing are the leading segments of the Japan IVD market.
  • Genetic Testing is the fastest-growing segment of the Japanese in-vitro diagnostics market.
  • Tumor Marker and Hematology segments are competing closely with each other to grab the maximum share of the pie.
  • The growth of the hematology market is attributed to factors such as the increasing incidences of blood disorders, the growing adoption of automated hematology instruments by diagnostic laboratories, the emergence of high throughput hematology analyzers, and the introduction of technologically advanced hematology instruments.
  • Microbiology testing is witnessing growth due to technological advancements and increasing infectious disease incidences.

Japan IVD Market - Company Analysis

  • In the Japan IVD market, Roche Diagnostics and Sysmex Corporation are the leading players.
  • Thermo Fisher Scientific Inc., Danaher Corporation, Abbott Laboratories, and Biomerieux are the other top four players in the Japan IVD market.
  • In the diagnostics business, Abbott will focus on driving sales growth from its Alinity suite of diagnostics instruments and its portfolio of rapid diagnostic testing systems.
  • In August 2023, Sysmex Corporation announced an expansion of the Global Business Partnership Agreement (GBPA) with Roche Diagnostics International Ltd.
  • In April 2023, bioMérieux submitted a 510(k) premarket notification to the U.S. FDA for the VITEK REVEAL, formerly known as SPECIFIC REVEAL Rapid AST System.
  • In October 2023, Sysmex and Fujirebio entered into a business collaboration agreement in the field of immunoassay, in a bid to promote cooperation to accelerate their global expansion, and to contribute to the development and advancement of immunoassay.

The report provides a comprehensive assessment of the fast-evolving, high-growth Japan IVD Market.

This 218 Pages report with 42 Figures and 4 Tables has been analyzed from 8 View Points:

1) Japan In-Vitro Diagnostics (IVD) Market and Forecast (2008 - 2030)
2) Japan IVD Market Share and Forecast (2008 - 2030)
3) Japan IVD Market & Forecast - By Segment (2008 - 2030)
4) Japan IVD Market & Forecast - Company Sales Analysis (2014 - 2030)
5) In-Vitro Diagnostics (IVD) Market - Major Deals
6) In-Vitro Diagnostics (IVD) Market - Recent Developments
7) Registration for In Vitro Diagnostic Devices in Japan
8) Japan IVD Market - Market Dynamics

Japan In-Vitro Diagnostics Market - By Segment

1. Urine & Feces
2. Hematology
3. Clinical Chemistry
4. SMBG
5. Tumor Marker
6. Immunoassay
7. Infectious Disease
8. Microbiology
9. Pathology
10. Genetic Testing
11. Others

Japan In-Vitro Diagnostics Market - Company Analysis

1. Roche Diagnostics
2. Abbott Laboratories
3. Danaher Corporation
4. bioMérieux S.A.
5. Sysmex Corporation
6. Bio-Rad Laboratories, Inc.
7. Becton Dickinson Company
8. Thermo Fisher Scientific Inc.
9. Others

Data Source

The publisher employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from the Proprietary Information Database, Primary and Secondary Research Methodologies, and In-house analysis by a dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interviews, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine, and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Reports, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents


1. Executive Summary
2. Japan In-Vitro Diagnostics (IVD) Market and Market Share Analysis - Forecast to 2030
2.1 Japan IVD Market and Forecast (2008 - 2030)
2.2 By Segment - Japan IVD Market Share and Forecast (2008 - 2030)
2.3 By Company - Japan IVD Share and Forecast (2015 - 2030)

3. Japan IVD - Segments Wise Market and Forecast (2008 - 2030)
3.1 Urine & Feces Market and Forecast
3.2 Hematology Market and Forecast
3.3 Clinical Chemistry Market and Forecast
3.4 SMBG Market and Forecast
3.5 Tumor Marker Market and Forecast
3.6 Immunoassay Market and Forecast
3.7 Infectious Disease Market and Forecast
3.8 Microbiology Market and Forecast
3.9 Pathology Market and Forecast
3.10 Genetic Testing Market and Forecast
3.11 Others Market and Forecast

4. Japan IVD Market - Company Analysis (2014 - 2030)
4.1 Roche Diagnostics
4.1.1 Company Overview
4.1.2 Roche Diagnostics - Japan IVD Sales and Forecast
4.1.3 Recent Developments
4.2 Abbott Laboratories
4.2.1 Company Overview
4.2.2 Abbott Laboratories - Japan IVD Sales and Forecast
4.2.3 Recent Developments
4.3 Danaher Corporation
4.3.1 Company Overview
4.3.2 Danaher Corporation - Japan IVD Sales and Forecast
4.3.3 Recent Developments
4.4 bioMérieux S.A.
4.4.1 Company Overview
4.4.2 Biomerieux - Japan IVD Sales and Forecast
4.4.3 Recent Developments
4.5 Sysmex Corporation
4.5.1 Company Overview
4.5.2 Sysmex Corporation - Japan IVD Sales and Forecast
4.5.3 Recent Developments
4.6 Bio-Rad Laboratories, Inc.
4.6.1 Company Overview
4.6.2 Bio-Rad Laboratories, Inc - Japan IVD Sales and Forecast
4.6.3 Recent Developments
4.7 Becton Dickinson and Company
4.7.1 Company Overview
4.7.2 Becton Dickinson and Company - Japan IVD Sales and Forecast
4.7.3 Recent Developments
4.8 Thermo Fisher Scientific Inc.
4.8.1 Company Overview
4.8.2 Thermo Fisher Scientific Inc. - Japan IVD Sales and Forecast
4.8.3 Recent Developments
4.9 Others - Japan IVD Sales and Forecast

5. In-Vitro Diagnostics (IVD) Market - Major Deals6. In-Vitro Diagnostics (IVD) Market - Recent Developments
7. Japan In-Vitro Diagnostics - Market Dynamics
7.1 Japan IVD Market - Driving Factors
7.2 Japan IVD Market - Challenges

List of Figures
Figure 2-1: Japan - IVD Market (Million US$), 2008 - 2023
Figure 2-2: Japan - Forecast for IVD Market (Million US$), 2024 - 2030
Figure 3-1: Japan - Urine & Feces Market (Million US$), 2008 - 2023
Figure 3-2: Japan - Forecast for Urine & Feces Market (Million US$), 2024 - 2030
Figure 3-3: Japan - Hematology Market (Million US$), 2008 - 2023
Figure 3-4: Japan - Forecast for Hematology Market (Million US$), 2024 - 2030
Figure 3-5: Japan - Clinical Chemistry Market (Million US$), 2008 - 2023
Figure 3-6: Japan - Forecast for Clinical Chemistry Market (Million US$), 2024 - 2030
Figure 3-7: Japan - SMBG Market (Million US$), 2008 - 2023
Figure 3-8: Japan - Forecast for SMBG Market (Million US$), 2024 - 2030
Figure 3-9: Japan - Tumor Marker Market (Million US$), 2008 - 2023
Figure 3-10: Japan - Forecast for Tumor Marker Market (Million US$), 2024 - 2030
Figure 3-11: Japan - Immunoassay Market (Million US$), 2008 - 2023
Figure 3-12: Japan - Forecast for Immunoassay Market (Million US$), 2024 - 2030
Figure 3-13: Japan - Infectious Disease Market (Million US$), 2008 - 2023
Figure 3-14: Japan - Forecast for Infectious disease Market (Million US$), 2024 - 2030
Figure 3-15: Japan - Microbiology Market (Million US$), 2008 - 2023
Figure 3-16: Japan - Forecast for Microbiology Market (Million US$), 2024 - 2030
Figure 3-17: Japan - Pathology Market (Million US$), 2008 - 2023
Figure 3-18: Japan - Forecast for Pathology Market (Million US$), 2024 - 2030
Figure 3-19: Japan - Genetic Testing Market (Million US$), 2008 - 2023
Figure 3-20: Japan - Forecast for Genetic Testing Market (Million US$), 2024 - 2030
Figure 3-21: Japan - Others Market (Million US$), 2008 - 2023
Figure 3-22: Japan - Forecast for Others Market (Million US$), 2024 - 2030
Figure 4-1: Roche Diagnostics - Japan IVD Sales (Million US$), 2012 - 2023
Figure 4-2: Roche Diagnostics - Forecast for Japan IVD Sales (Million US$), 2024 - 2030
Figure 4-3: Abbott Laboratories - Japan IVD Sales (Million US$), 2012 - 2023
Figure 4-4: Abbott Laboratories - Forecast for Japan IVD Sales (Million US$), 2024 - 2030
Figure 4-5: Danaher Corporation - Japan IVD Sales (Million US$), 2014 - 2023
Figure 4-6: Danaher Corporation - Forecast for Japan IVD Sales (Million US$), 2024 - 2030
Figure 4-7: biomerieux - Japan IVD Sales (Million US$), 2015 - 2023
Figure 4-8: Biomerieux - Forecast for Japan IVD Sales (Million US$), 2024 - 2030
Figure 4-9: Sysmex Corporation - Japan IVD Sales (Million US$), 2010 - 2023
Figure 4-10: Sysmex Corporation - Forecast for Japan IVD Sales (Million US$), 2024 - 2030
Figure 4-11: Bio-Rad Laboratories, Inc - Japan IVD Sales (Million US$), 2014 - 2023
Figure 4-12: Bio-Rad Laboratories, Inc - Forecast for Japan IVD Sales (Million US$), 2024 - 2030
Figure 4-13: Becton Dickinson and Company - Japan IVD Sales (Million US$), 2014 - 2023
Figure 4-14: Becton Dickinson and Company - Forecast for Japan IVD Sales (Million US$), 2024 - 2030
Figure 4-15: Thermo Fisher Scientific Inc. - Japan IVD Sales (Million US$), 2014 - 2023
Figure 4-16: Thermo Fisher Scientific Inc. - Forecast for Japan IVD Sales (Million US$), 2024 - 2030
Figure 4-17: Others - Japan IVD Sales (Million US$), 2015 - 2023
Figure 4-18: Others - Forecast for Japan IVD Sales (Million US$), 2024 - 2030

List of Tables
Table 2-1: By Segment - Japan IVD Market Share (Percent), 2008 - 2023
Table 2-2: By Segment - Forecast for Japan IVD Market Share (Percent), 2024 - 2030
Table 2-3: By Company - Japan IVD Market Share (Percent), 2015 - 2023
Table 2-4: By Company - Forecast for Japan IVD Market Share (Percent), 2024 - 2030

Companies Mentioned

  • Abbott Laboratories
  • Becton Dickinson Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux S.A.
  • Danaher Corporation
  • Roche Diagnostics 
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.